Canada Biotechnology & Medical Research

Nirvana Life Sciences Inc (NIRV)

Track

Ticker: NIRV Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Clark, Bruce Andrew James Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
207.06
Quantity 79,619 -11.8%
Value CA$451,190
Clark, Bruce Andrew James Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
246.44
Quantity 18,925 +34.0%
Value CA$1,391,176
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
386.78
Quantity 94,894 -10.9%
Value CA$1,191,535
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.05
Quantity 574,322 +382.9%
Value CA$28,716
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.05
Quantity 439,567
Value CA$21,978
2.7
Inwentash, Jakson Samuel Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.05
Quantity 439,567
Value CA$21,978
Clark, Bruce Andrew James Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.05
Quantity 2,000,000 +117.2%
Value CA$100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-29 2025-07-25 B Purchase
Clark, Bruce Andrew James

Director of Issuer, Senior Officer of Issuer

Executive Director
79,619 -11.8%
207.06
CA$451,190 		79,619 -11.8% 207.06 CA$451,190
2025-07-29 2025-07-25 B Purchase
Clark, Bruce Andrew James

Director of Issuer, Senior Officer of Issuer

Executive Director
18,925 +34.0%
246.44
CA$1,391,176 		18,925 +34.0% 246.44 CA$1,391,176
2025-10-11 2025-07-04 B Purchase
2.5
Inwentash, Sheldon

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
94,894 -10.9%
386.78
CA$1,191,535 		94,894 -10.9% 386.78 CA$1,191,535
2025-10-10 2025-07-04 B Purchase
2.5
Inwentash, Sheldon

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
574,322 +382.9%
0.05
CA$28,716 		574,322 +382.9% 0.05 CA$28,716
2025-10-10 2025-07-04 B Purchase
2.5
Inwentash, Sheldon

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
439,567
0.05
CA$21,978 		439,567 0.05 CA$21,978
2025-10-10 2025-07-04 B Purchase
2.7
Inwentash, Jakson Samuel

Director of Issuer

Non-Executive Director
439,567
0.05
CA$21,978 		439,567 0.05 CA$21,978
2023-05-18 2023-05-17 B Purchase
Clark, Bruce Andrew James

Director of Issuer, Senior Officer of Issuer

Executive Director
2,000,000 +117.2%
0.05
CA$100,000 		2,000,000 +117.2% 0.05 CA$100,000
Explore more

More insider trading research around Nirvana Life Sciences Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America